单期对比增强双能CT不同碘定量方法鉴别肾细胞癌亚型:面积法与容积法分析
该回顾性研究纳入110例患者113个经病理证实的肾细胞癌,在术前肾图期行双能CT扫描,由两名放射科医师独立测量最大强化层面面积法碘浓度、最大面积层面面积法碘浓度及全肿瘤容积法碘浓度,评估单期肾图期鉴别肾细胞癌亚型的诊断效能并比较三种方法,结果显示最大强化层面面积法碘浓度鉴别透明细胞癌与乳头状癌的AUC显著高于最大面积层面面积法(P=0.0357)和容积法(P=0.0206)。
要点
- 单期肾图期双能CT碘定量可在术前鉴别肾细胞癌亚型。
- 最大强化层面面积法碘浓度鉴别透明细胞癌与乳头状癌的AUC最高。
- 三种碘定量方法鉴别透明细胞癌与嫌色细胞癌的AUC无显著差异。
核心结论
- 单期肾图期碘定量可用于术前鉴别肾细胞癌亚型,最大强化层面面积法碘定量可能是最合适的方法。
研究设计与样本
- 回顾性研究,纳入110例患者113个经组织病理学证实的肾细胞癌,术前在肾图期行双能CT扫描,由两名独立放射科医师测量三种碘定量参数,以病理为参考标准。
关键影像表现/征象
- 透明细胞癌与乳头状癌之间、透明细胞癌与嫌色细胞癌之间在肾图期三种碘定量方法均存在显著差异。
- 乳头状癌与嫌色细胞癌之间在肾图期三种碘定量方法均无显著差异。
诊断标准与关键数值
- 最大强化层面面积法碘浓度鉴别透明细胞癌与乳头状癌的AUC显著高于最大面积层面面积法(P=0.0357)。
- 最大强化层面面积法碘浓度鉴别透明细胞癌与乳头状癌的AUC显著高于容积法(P=0.0206)。
- 三种碘定量方法鉴别透明细胞癌与嫌色细胞癌的AUC无显著差异。
- 三种碘定量参数的组内相关系数均超过0.8,可靠性很高。
临床应用与阅片要点
- 在肾图期单期双能CT碘定量中,最大强化层面面积法碘定量可能最适于术前鉴别肾细胞癌亚型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate the possibility of iodine quantification during a single nephrographic phase in characterizing renal cell carcinoma (RCC) subtypes and if there is a difference between areal and volumetric iodine quantification methods.
MATERIALS AND METHODS: This retrospective study included 110 patients with 113 histopathologically confirmed RCCs scanned by dual-energy CT at the nephrographic phase before surgeries. For each lesion, an areal measurement of the iodine concentration with maximum enhancement (I max enhan) and the iodine concentration with maximum area among slices (I max area), as well as a volumetric iodine concentration of the whole-tumor (I volume), were evaluated by two independent radiologists. The diagnostic performances in a single nephrographic phase for characterizing RCC subtypes were evaluated, and three iodine quantification methods were compared with each other.
RESULTS: There were significant differences (clear cell vs. papillary and clear cell vs. chromophobe RCC) and no significant differences (papillary vs. chromophobe RCC) at the nephrographic phase in all three methods. The area under the receiver operating characteristic (ROC) curve (AUC) derived from the I max enhan for discriminating clear cell from papillary RCC was significantly higher than that derived from the I max area (P = 0.0357) and the I volume (P = 0.0206), and no significant differences existed among the three methods in distinguishing clear cell RCC from chromophobe RCC. The reliability of all three parameters was very high with an interclass correlation coefficient (ICC) exceeding 0.8.
CONCLUSIONS: Iodine quantification in a single nephrographic phase can be used to differentiate RCC subtypes preoperatively, and the areal maximum enhancement iodine quantification would probably be the most appropriate approach.
引用
- Dai C, Cao Y, Jia Y, et al. Differentiation of renal cell carcinoma subtypes with different iodine quantification methods using single-phase contrast-enhanced dual-energy CT: areal vs. volumetric analyses. Abdom Radiol (NY). 2018. PMID: 28721478. doi:10.1007/s00261-017-1253-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。